Literature DB >> 25808502

Redefining phenotypes associated with mitochondrial DNA single deletion.

Michelangelo Mancuso1, Daniele Orsucci, Corrado Angelini, Enrico Bertini, Valerio Carelli, Giacomo Pietro Comi, Maria Alice Donati, Antonio Federico, Carlo Minetti, Maurizio Moggio, Tiziana Mongini, Filippo Maria Santorelli, Serenella Servidei, Paola Tonin, Antonio Toscano, Claudio Bruno, Luca Bello, Elena Caldarazzo Ienco, Elena Cardaioli, Michela Catteruccia, Paola Da Pozzo, Massimiliano Filosto, Costanza Lamperti, Isabella Moroni, Olimpia Musumeci, Elena Pegoraro, Dario Ronchi, Donato Sauchelli, Mauro Scarpelli, Monica Sciacco, Maria Lucia Valentino, Liliana Vercelli, Massimo Zeviani, Gabriele Siciliano.   

Abstract

Progressive external ophthalmoplegia (PEO), Kearns-Sayre syndrome (KSS) and Pearson syndrome are the three sporadic clinical syndromes classically associated with single large-scale deletions of mitochondrial DNA (mtDNA). PEO plus is a term frequently utilized in the clinical setting to identify patients with PEO and some degree of multisystem involvement, but a precise definition is not available. The purpose of the present study is to better define the clinical phenotypes associated with a single mtDNA deletion, by a retrospective study on a large cohort of 228 patients from the database of the "Nation-wide Italian Collaborative Network of Mitochondrial Diseases". In our database, single deletions account for about a third of all patients with mtDNA-related disease, more than previously recognized. We elaborated new criteria for the definition of PEO and "KSS spectrum" (a category of which classic KSS represents the most severe extreme). The criteria for "KSS spectrum" include the resulting multisystem clinical features associated with the KSS features, and which therefore can predict their presence or subsequent development. With the new criteria, we were able to classify nearly all our single-deletion patients: 64.5% PEO, 31.6% KSS spectrum (including classic KSS 6.6%) and 2.6% Pearson syndrome. The deletion length was greater in KSS spectrum than in PEO, whereas heteroplasmy was inversely related with age at onset. We believe that the new phenotype definitions implemented here may contribute to a more homogeneous patient categorization, which will be useful in future cohort studies of natural history and clinical trials.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25808502     DOI: 10.1007/s00415-015-7710-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

Review 1.  Mitochondrial respiratory-chain diseases.

Authors:  Salvatore DiMauro; Eric A Schon
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

2.  CPEO and KSS differ in the percentage and location of the mtDNA deletion.

Authors:  Ester López-Gallardo; Manuel J López-Pérez; Julio Montoya; Eduardo Ruiz-Pesini
Journal:  Mitochondrion       Date:  2009-05-04       Impact factor: 4.160

3.  Ocular myopathy and mitochondrial DNA deletion. A presentation of seven identified Danish patients.

Authors:  P J Magalhães; O Sjö; S Nørby
Journal:  Acta Ophthalmol Scand Suppl       Date:  1996

4.  Diagnostic criteria for respiratory chain disorders in adults and children.

Authors:  F P Bernier; A Boneh; X Dennett; C W Chow; M A Cleary; D R Thorburn
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

5.  New insights into the metabolic consequences of large-scale mtDNA deletions: a quantitative analysis of biochemical, morphological, and genetic findings in human skeletal muscle.

Authors:  R Schröder; S Vielhaber; F R Wiedemann; C Kornblum; A Papassotiropoulos; P Broich; S Zierz; C E Elger; H Reichmann; P Seibel; T Klockgether; W S Kunz
Journal:  J Neuropathol Exp Neurol       Date:  2000-05       Impact factor: 3.685

6.  Single large-scale mitochondrial DNA deletion in a patient with mitochondrial myopathy associated with multiple symmetric lipomatosis.

Authors:  Y Campos; M A Martín; C Navarro; P Gordo; J Arenas
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

7.  Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies.

Authors:  I J Holt; A E Harding; J A Morgan-Hughes
Journal:  Nature       Date:  1988-02-25       Impact factor: 49.962

Review 8.  Diagnostic approach to mitochondrial disorders: the need for a reliable biomarker.

Authors:  M Mancuso; D Orsucci; F Coppedè; C Nesti; A Choub; G Siciliano
Journal:  Curr Mol Med       Date:  2009-12       Impact factor: 2.222

9.  Single deletions in mitochondrial DNA--molecular mechanisms and disease phenotypes in clinical practice.

Authors:  R D S Pitceathly; S Rahman; M G Hanna
Journal:  Neuromuscul Disord       Date:  2012-05-09       Impact factor: 4.296

10.  Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia.

Authors:  Alejandro Horga; Robert D S Pitceathly; Julian C Blake; Catherine E Woodward; Pedro Zapater; Carl Fratter; Ese E Mudanohwo; Gordon T Plant; Henry Houlden; Mary G Sweeney; Michael G Hanna; Mary M Reilly
Journal:  Brain       Date:  2014-10-03       Impact factor: 13.501

View more
  27 in total

1.  Sporadic chronic progressive external ophthalmoplegia with single large mitochondrial DNA deletion and neurogenic findings.

Authors:  Lucia Ruggiero; Chiara Fiorillo; Claudia Nesti; Fiore Manganelli; Rosa Iodice; Marcello Esposito; Filippo Maria Santorelli; Lucio Santoro
Journal:  J Neurol       Date:  2017-02-07       Impact factor: 4.849

Review 2.  "Orbiting around" the orbital myositis: clinical features, differential diagnosis and therapy.

Authors:  F Montagnese; S Wenninger; B Schoser
Journal:  J Neurol       Date:  2015-10-17       Impact factor: 4.849

3.  Revisiting mitochondrial ocular myopathies: a study from the Italian Network.

Authors:  D Orsucci; C Angelini; E Bertini; V Carelli; G P Comi; A Federico; C Minetti; M Moggio; T Mongini; F M Santorelli; S Servidei; P Tonin; A Ardissone; L Bello; C Bruno; E Caldarazzo Ienco; D Diodato; M Filosto; C Lamperti; I Moroni; O Musumeci; E Pegoraro; G Primiano; D Ronchi; A Rubegni; S Salvatore; M Sciacco; M L Valentino; L Vercelli; A Toscano; M Zeviani; G Siciliano; M Mancuso
Journal:  J Neurol       Date:  2017-07-10       Impact factor: 4.849

Review 4.  Time to harmonize mitochondrial syndrome nomenclature and classification: A consensus from the North American Mitochondrial Disease Consortium (NAMDC).

Authors:  Valentina Emmanuele; Jaya Ganesh; Georgirene Vladutiu; Richard Haas; Douglas Kerr; Russell P Saneto; Bruce H Cohen; Johan L K Van Hove; Fernando Scaglia; Charles Hoppel; Xiomara Q Rosales; Emanuele Barca; Richard Buchsbaum; John L Thompson; Salvatore DiMauro; Michio Hirano
Journal:  Mol Genet Metab       Date:  2022-05-13       Impact factor: 4.204

5.  Mitochondrial epilepsy: a cross-sectional nationwide Italian survey.

Authors:  Chiara Ticci; Federico Sicca; Anna Ardissone; Enrico Bertini; Valerio Carelli; Daria Diodato; Lidia Di Vito; Massimiliano Filosto; Chiara La Morgia; Costanza Lamperti; Diego Martinelli; Isabella Moroni; Olimpia Musumeci; Daniele Orsucci; Elia Pancheri; Lorenzo Peverelli; Guido Primiano; Anna Rubegni; Serenella Servidei; Gabriele Siciliano; Costanza Simoncini; Paola Tonin; Antonio Toscano; Michelangelo Mancuso; Filippo M Santorelli
Journal:  Neurogenetics       Date:  2020-01-03       Impact factor: 2.660

Review 6.  Progressive External Ophthalmoplegia.

Authors:  Collin McClelland; Georgios Manousakis; Michael S Lee
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

7.  Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases.

Authors:  Chiara Ticci; Daniele Orsucci; Anna Ardissone; Luca Bello; Enrico Bertini; Irene Bonato; Claudio Bruno; Valerio Carelli; Daria Diodato; Stefano Doccini; Maria Alice Donati; Claudia Dosi; Massimiliano Filosto; Chiara Fiorillo; Chiara La Morgia; Costanza Lamperti; Silvia Marchet; Diego Martinelli; Carlo Minetti; Maurizio Moggio; Tiziana Enrica Mongini; Vincenzo Montano; Isabella Moroni; Olimpia Musumeci; Elia Pancheri; Elena Pegoraro; Guido Primiano; Elena Procopio; Anna Rubegni; Roberta Scalise; Monica Sciacco; Serenella Servidei; Gabriele Siciliano; Costanza Simoncini; Deborah Tolomeo; Paola Tonin; Antonio Toscano; Flavia Tubili; Michelangelo Mancuso; Roberta Battini; Filippo Maria Santorelli
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

8.  Mitochondrial pathology in progressive cerebellar ataxia.

Authors:  David Bargiela; Priya Shanmugarajah; Patrick F Chinnery; Marios Hadjivassiliou; Christine Lo; Emma L Blakely; Robert W Taylor; Rita Horvath; Stephen Wharton
Journal:  Cerebellum Ataxias       Date:  2015-12-04

9.  Diagnosing Kearns-Sayre Syndrome Requires Genetic Confirmation.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Chin Med J (Engl)       Date:  2016-09-20       Impact factor: 2.628

Review 10.  The genetics and pathology of mitochondrial disease.

Authors:  Charlotte L Alston; Mariana C Rocha; Nichola Z Lax; Doug M Turnbull; Robert W Taylor
Journal:  J Pathol       Date:  2016-11-02       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.